SCHEMBL15801481

SCHEMBL15801481

CCC/C(=C/CO)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22575579 0.88 MEN1 (0.35)
SCHEMBL27502249 0.84 CES1 (0.36)
SCHEMBL12654720 0.83
SCHEMBL6748303 0.83
SCHEMBL8573776 0.81 SQLE (0.43)
SCHEMBL8573777 0.81 SQLE (0.43)
SCHEMBL11831125 0.80 CES2 (0.41)
SCHEMBL11053685 0.80 CES2 (0.41)
SCHEMBL1389553 0.77 SQLE (0.41)
SCHEMBL1389555 0.77 SQLE (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682111-B2 Method for preventing or treating neurodegenerative diseases SU WEIWEI (CN) 2017-06-20 US disclosed
US-9527827-B2 C-9 oxygen functionalized labdane derivates COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-12-27 US disclosed
US-9527827-B2 C-9 oxygen functionalized labdane derivates COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-12-27 US disclosed
US-20160082059-A1 METHOD FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES SU WEIWEI (CN) 2016-03-24 US disclosed
US-20140171498-A1 C-9 OXYGEN FUNCTIONALIZED LABDANE DERIVATES Council of Scientific & Indusrtial Reasearch (IN) 2014-06-19 US disclosed
US-20140171498-A1 C-9 OXYGEN FUNCTIONALIZED LABDANE DERIVATES Council of Scientific & Indusrtial Reasearch (IN) 2014-06-19 US disclosed